Company record
Pfizer
0 FDA warning letters since 2023 and 3 recalls in the last 12 months.
Get an email the day FDA posts anything new about Pfizer.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Oct 28 | Class II | Pfizer Drug |
Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01. Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing. |
| Oct 28 | Class II | Pfizer Drug |
Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10 Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing. |
| Sep 23 | Class II | Pfizer Drug |
Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01. Lack of Assurance of Sterility |